DiscoverClosing BellClosing Bell Overtime: IAC CEO On Potentially Spinning Off Angi and M&A Opportunities; Insulet CEO On Strong Pump Demand and Expanding In The Type 2 Diabetes Market 11/11/24
Closing Bell Overtime: IAC CEO On Potentially Spinning Off Angi and M&A Opportunities; Insulet CEO On Strong Pump Demand and Expanding In The Type 2 Diabetes Market 11/11/24

Closing Bell Overtime: IAC CEO On Potentially Spinning Off Angi and M&A Opportunities; Insulet CEO On Strong Pump Demand and Expanding In The Type 2 Diabetes Market 11/11/24

Update: 2024-11-11
Share

Description

The Dow closed above 44,000 and the S&P 500 closed above 6,000 for the first time as stocks extend their bullish run since the election. Bespoke’s Paul Hickey and Envestnet’s Dana D’Auria break down what could be ahead through year-end. Apollo Global’s Torsten Slok on the Fed’s next move. Insulet CEO Jim Hollingshead on the company seeing strong demand for its insulin pump. IAC CEO Joey Levin on the company’s decision to explore spinning off its ownership in Angi—and what he might do with the cash. 

Comments 
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Closing Bell Overtime: IAC CEO On Potentially Spinning Off Angi and M&A Opportunities; Insulet CEO On Strong Pump Demand and Expanding In The Type 2 Diabetes Market 11/11/24

Closing Bell Overtime: IAC CEO On Potentially Spinning Off Angi and M&A Opportunities; Insulet CEO On Strong Pump Demand and Expanding In The Type 2 Diabetes Market 11/11/24

CNBC